Belite Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	1,285	1,139	726
Market Cap Growth	-	56.83%	-
Enterprise Value	1,198	1,052	685
PE Ratio	-36.01	-36.01	-57.43
PB Ratio	14.21	12.60	17.50
P/FCF Ratio	-38.10	-38.10	-61.29
P/OCF Ratio	-38.18	-38.18	-63.39
EV/EBITDA Ratio	-33.71	-33.71	-55.10
EV/EBIT Ratio	-33.29	-33.29	-54.24
EV/FCF Ratio	-35.18	-35.18	-57.81
Debt / Equity Ratio	0.01	0.01	0.02
Debt / EBITDA Ratio	-0.03	-0.03	-0.07
Debt / FCF Ratio	-0.03	-0.03	-0.07
Quick Ratio	24.50	24.50	20.01
Current Ratio	24.76	24.76	20.35
Interest Coverage	-1263.92	-1263.92	-789.50
Return on Equity (ROE)	-48.00%	-48.00%	-95.80%
Return on Assets (ROA)	-45.50%	-45.50%	-40.40%
Return on Capital (ROIC)	-34.68%	-34.68%	-30.26%
Earnings Yield	-2.46%	-2.78%	-1.74%
FCF Yield	-2.33%	-2.62%	-1.63%
Buyback Yield / Dilution	-33.12%	-33.12%	-108.74%
Total Shareholder Return	-33.12%	-33.12%	-108.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).